These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22670594)

  • 1. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.
    Pisetsky DS
    Scand J Immunol; 2012 Sep; 76(3):223-8. PubMed ID: 22670594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of antinuclear antibody production in the rheumatic diseases.
    Pisetsky DS
    Rheum Dis Clin North Am; 1987 Dec; 13(3):569-81. PubMed ID: 3324206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1986 Mar; 6(1):41-53. PubMed ID: 2420510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE.
    Pisetsky DS
    Autoimmunity; 2014 Dec; 47(8):487-93. PubMed ID: 24916843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenic role of antinuclear antibodies in lupus disease].
    Sany J
    Ann Med Interne (Paris); 1990; 141(3):222-6. PubMed ID: 2195947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-U1RNP antibodies and lupus nephritis].
    Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
    Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies: clinical correlations and biologic significance.
    Sontheimer RD; McCauliffe DP; Zappi E; Targoff I
    Adv Dermatol; 1992; 7():3-52; discussion 53. PubMed ID: 1371222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of innate immunity in the induction of autoimmunity.
    Pisetsky DS
    Autoimmun Rev; 2008 Oct; 8(1):69-72. PubMed ID: 18708168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
    Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
    Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity.
    Tan EM
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S3-9. PubMed ID: 2456507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus.
    Putterman C
    Autoimmun Rev; 2004 Feb; 3(2):7-11. PubMed ID: 15003182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the scientific understanding of lupus.
    Ardoin SP; Pisetsky DS
    Arthritis Res Ther; 2008; 10(5):218. PubMed ID: 18947369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.